Advanced Inhalation Therapies closed a $10.2 million offering yesterday. According to regulatory filings, 39 investors contributed to the offering, which made its 1st sale on Jan. 13. The Israel-based company is developing a drug delivery device to treat severe respiratory infections and lung diseases using a high dose of nitric oxide. The company plans to use $604,000 […]